Evaluation of the Impact of Metabolic Syndrome on Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease

KANİ H. T., DEMİRTAŞ C. Ö., KEKLİKKIRAN Ç., Ergenc I., Mehdiyev S., AKDENİZ E., ...More

TURKISH JOURNAL OF GASTROENTEROLOGY, vol.32, no.8, pp.661-666, 2021 (SCI-Expanded) identifier identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 32 Issue: 8
  • Publication Date: 2021
  • Doi Number: 10.5152/tjg.2021.20512
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.661-666
  • Keywords: Fibrosis, metabolic syndrome, metabolic dysfunction-associated fatty liver disease, SEVERITY, STEATOHEPATITIS, PROGRESSION, OUTCOMES, NAFLD
  • Recep Tayyip Erdoğan University Affiliated: No


Background: Metabolic syndrome (MS) is a condition that consists of several disorders, and the individual impact of these disorders on metabolic dysfunction-associated fatty liver disease (MAFLD) is still not clear in a combined diagnosis of MS. In this study, we aimed to investigate the effect of MS on advanced fibrosis in patients with MAFLD.